![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Sosnovik David E Muller James E Brady Thomas J Kathiresan Sekar
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.11, Iss.5, 2002-05, pp. : 693-704
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Agents that stabilise atherosclerotic plaque
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Non-Invasive Radiotracer Imaging as a Tool for Drug Development
Current Pharmaceutical Design, Vol. 6, Iss. 10, 2000-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Current Drug Targets, Vol. 16, Iss. 4, 2015-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Morphology of Atherosclerotic Plaque: Its Feature by Imaging Study
Current Pharmaceutical Design, Vol. 14, Iss. 18, 2008-06 ,pp. :